ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
1.74
-0.01 (-0.57%)
At close: Oct 01, 2025, 1:44 PM
-0.57% (1D)
| Bid | 1.7 |
| Market Cap | 80.31M |
| Revenue (ttm) | 24.52M |
| Net Income (ttm) | -30.23M |
| EPS (ttm) | -0.66 |
| PE Ratio (ttm) | -2.64 |
| Forward PE | -8.19 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.78 |
| Volume | 23,243 |
| Avg. Volume (20D) | 2,912,741 |
| Open | 1.75 |
| Previous Close | 1.75 |
| Day's Range | 1.74 - 1.84 |
| 52-Week Range | 0.27 - 3.25 |
| Beta | 0.49 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for IPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsImmunoPrecise Antibodies Ltd. is scheduled to release its earnings on
Sep 19, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-14.36%
ImmunoPrecise Antibodies shares are trading lower ...
Unlock content with
Pro Subscription
2 months ago
+26.92%
ImmunoPrecise Antibodies shares are trading higher after the company announced positive results from a newly expanded study for lensai immunogenicity screening.
1 month ago · fool.com
ImmunoPrecise (IPA) Q4 2025 Earnings TranscriptImage source: The Motley Fool.
2 months ago · seekingalpha.com
ImmunoPrecise Antibodies Ltd. (IPA) Q4 2025 Earnings Conference Call TranscriptImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q4 2025 Earnings Call July 29, 2025 10:30 AM ET Company Participants Jennifer Lynne Bath - CEO, President & Non-Independent Director Joseph Scheffler - Inte...
2 months ago · businesswire.com
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory BoardAUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation ...
